Chordate Medical (Sweden) Market Value
| CMH Stock | 12.55 0.25 1.95% |
| Symbol | Chordate |
Chordate Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Chordate Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Chordate Medical.
| 10/23/2024 |
| 12/22/2024 |
If you would invest 0.00 in Chordate Medical on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Chordate Medical Holding or generate 0.0% return on investment in Chordate Medical over 60 days. Chordate Medical is related to or competes with Sinch AB, Hexatronic Group, Surgical Science, Embracer Group, and SBB-B. More
Chordate Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Chordate Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Chordate Medical Holding upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 31.05 | |||
| Value At Risk | (9.59) | |||
| Potential Upside | 12.85 |
Chordate Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chordate Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Chordate Medical's standard deviation. In reality, there are many statistical measures that can use Chordate Medical historical prices to predict the future Chordate Medical's volatility.| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.84) | |||
| Total Risk Alpha | (1.00) | |||
| Treynor Ratio | (5.22) |
Chordate Medical Holding Backtested Returns
Chordate Medical Holding secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14% return per unit of risk over the last 3 months. Chordate Medical Holding exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Chordate Medical's Standard Deviation of 5.91, mean deviation of 4.2, and Risk Adjusted Performance of (0.10) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.16, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Chordate Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Chordate Medical is expected to be smaller as well. At this point, Chordate Medical Holding has a negative expected return of -0.8%. Please make sure to confirm Chordate Medical's maximum drawdown, daily balance of power, period momentum indicator, as well as the relationship between the skewness and day typical price , to decide if Chordate Medical Holding performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.89 |
Very good predictability
Chordate Medical Holding has very good predictability. Overlapping area represents the amount of predictability between Chordate Medical time series from 23rd of October 2024 to 22nd of November 2024 and 22nd of November 2024 to 22nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Chordate Medical Holding price movement. The serial correlation of 0.89 indicates that approximately 89.0% of current Chordate Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.89 | |
| Spearman Rank Test | 0.91 | |
| Residual Average | 0.0 | |
| Price Variance | 7.13 |
Chordate Medical Holding lagged returns against current returns
Autocorrelation, which is Chordate Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Chordate Medical's stock expected returns. We can calculate the autocorrelation of Chordate Medical returns to help us make a trade decision. For example, suppose you find that Chordate Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Chordate Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Chordate Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Chordate Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Chordate Medical stock over time.
Current vs Lagged Prices |
| Timeline |
Chordate Medical Lagged Returns
When evaluating Chordate Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Chordate Medical stock have on its future price. Chordate Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Chordate Medical autocorrelation shows the relationship between Chordate Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Chordate Medical Holding.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.